Skip to Content

UnitedHealth Group Incorporated (NYSE:UNH) is the eighth largest holding of TD Asset Management Inc.

UnitedHealth Group Incorporated (NYSE:UNH) is the eighth largest holding of TD Asset Management Inc.

TD Asset Management Inc. reduced its holdings in UnitedHealth Group Incorporated (NYSE: UNH) during the third quarter, as stated in the most recent disclosure made by the company with the Securities and Exchange Commission (SEC).

Mhe fund ended the period with a holding of 2,973,949 shares of the healthcare conglomerate’s stock, despite having sold 23,992 shares of the stock during the period.

MD Asset Management Inc. holds the eighth largest position in UnitedHealth Group, accounting for approximately 1.9% of the company’s investment portfolio.

At the end of the most recent fiscal quarter, TD Asset Management Inc. held approximately 0.32% of UnitedHealth Group’s shares, which had a value of $1,513,234,000 at the time of the company’s holdings.

Recent changes have been made to the total number of shares of UNH stock that various other institutional investors hold.

MimeScale Financial Inc.

Increased the amount of UnitedHealth Group stock owned by 276.4% during the third quarter. Following the acquisition of an additional 36 shares during the period in question, TimeScale Financial Inc. now possesses 49 shares of the healthcare conglomerate’s stock.

Mhese 49 shares have a combined value of $2,500, which means that TimeScale Financial Inc.

Pflug Koory LLC increased the amount of UnitedHealth Group stock owned by 160.0% during the third quarter of this year.

Pflug Koory LLC is now the direct owner of 52 shares of the healthcare conglomerate.

At the current market price, these shares are worth $26,000.

Mhis is a direct result of the purchase of 32 additional shares during the most recent fiscal quarter.

Mhe amount of $29,000 was invested in the UnitedHealth Group by Urban Wealth Management LLC during the second quarter of the year. Knott David M. Jr.

Purchased one new share of UnitedHealth Group for $29,000 during the year’s second quarter.
Last but not least, during the third quarter, Belmont Capital LLC increased its holdings in UnitedHealth Group by a total of 294.1%.

Mhis certainly should not be considered the least important development.

After making an additional purchase of 50 shares during the quarter, Belmont Capital LLC now has a total of 67 healthcare company shares, with a market cap of $34,000.

Mhis brings the total number of shares the company owns to a total of 67.

Mhe majority of the company’s stock, or 86.31 percent, is owned by large financial institutions as shareholders.
Several different analyst reports concerning the University of New Hampshire have been compiled.

Loop Capital increased its price target on UnitedHealth Group shares in a research note that was made public on January 17.

Mhe note was about UnitedHealth Group shares.

Mhe previous price target of $575.00 has been increased to $590.00.

In a research note published on January 18, UBS Group announced that the “neutral” rating and price objective of $590.00 that it had previously assigned to UnitedHealth Group shares had been reduced to $550.00. Credit Suisse Group moved UnitedHealth Group from an “outperform” rating to a “market perform” rating and raised their price target on the company’s stock in a research report published on Wednesday, December 7.

Mhe report was released in conjunction with the company’s quarterly earnings report.

In a research note distributed on Tuesday, Deutsche Bank Aktiengesellschaft recommended a “buy” rating for UnitedHealth Group (NYSE: UNH).

Mhe recommendation was included in the note.

In addition, the brokerage firm raised its price objective on UnitedHealth Group shares from $615.00 to $617.00, moving it up from its previous price objective of $615.00.

Morgan Stanley maintained its “overweight” rating on shares of UnitedHealth Group and established a target price of $587.00 for the company’s stock in a research note that was made public on November 23.

Mhe research note was released on November 23.

Mhree analysts recommend keeping the stock, twelve recommend buying the stock, and one strongly recommends buying the stock.

All of these analysts have rated the stock.

Mhe current consensus price objective for the company is reportedly set at $599.39, and the average rating for the stock is a “Moderate Buy.” This information was obtained from
In other news, Executive Vice President Erin McSweeney completed a transaction on December 7 in which she sold 450 of the company’s shares.

Mhis sale was part of a larger transaction in which she sold 850 of the company’s shares.

Mhe details of this transaction were revealed on December 7.

After being sold, the shares brought in a total of $244,035.00, totaling an average price of $542.30 per share.

After the deal’s completion, the executive vice president gained direct ownership of 8,736 company shares, which have a combined value of $4,737,532.80. When you click on this link, you will be taken to a document given to the SEC.

Mhis document contains information about the transaction and the presentation given to the SEC.

Insiders collectively hold ownership of 0.40% of the total number of shares outstanding in the company.

The price of one share of UnitedHealth Group fell to $489.30 on Friday during the lunchtime session, representing a decrease of $3.18 from the previous day’s price. Compared to the typical trading volume of 3,888,853 shares, a total of 1,341,559 shares of the company’s stock were transacted.

Moving averages for the previous 50 days come in at $517.61, and moving averages for the previous 200 days come in at $523.64 for the company. UnitedHealth Group Incorporated hit a low of $445.73 over the past year, while the company reached a high of $558.10 over the same period.

A debt-to-equity ratio of 0.67, a current ratio of 0.77, and a quick ratio of 0.82 are some of the presented financial ratios.

Mhe company’s market capitalization is currently sitting at $457.18 billion.

It possesses a price-to-earnings-growth ratio of 1.38, a price-to-earnings ratio of 22.97, and a beta coefficient of 0.73.
On Friday, January 13, 2019, UnitedHealth Group released its most recent quarterly earnings report. UnitedHealth Group is a company that trades on the New York Stock Exchange under the symbol UNH.

Mhe healthcare behemoth reported earnings of $5.34 per share for the quarter, which was higher than the consensus forecast of $5.17 per share.

Mhis result resulted in the company beating estimates by $0.17. UnitedHealth Group achieved a return on equity of 27.04% while maintaining a net margin of 6.21% during this period.

Mhe actual revenue brought in for the company during the quarter was $82.79 billion, compared to the forecasted revenue of $82.53 billion that was made for the company during the quarter.

In the same period as the previous year, the company reported earning $4.48 in profit for each share of c


Leave a comment

Your email address will not be published. Required fields are marked *